Single Site, Masked, Randomized, Controlled Study to Assess Efficacy of Osurdex as Adjunct to Avastin Compared With Avastin Alone in the Treatment of Patients With Macular Edema Due to Central or Branch Retinal Vein Occlusion

Completed · Phase 4

Conditions studied: Retinal Vein Occlusions

In brief

Comparative study to see if treating with Osurdex in addition to Avastin in patients with retinal vein occlusions helps increased visual acuity outcomes

Key facts

Study ID

NCT01085734

Run by

Maturi, Raj K., M.D., P.C.

People needed

30

Starts

2010-03-01

Expected to finish

2011-10-01

Last updated by the study team

2014-04-21

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• male or female age 18 years or older
• Branch retinal vein occlusion or central retinal vein occlusion of less than one year duration
• Best correct visual acuity of greater than 24 and less than 80
• Presence of macular edema defined as OCT central subfield thickness of >250

You may not qualify if…

• intravitreal anti-VEGF treatment in study eye within six weeks of baseline
• intravitreal steroid treatment in the study eye within eight weeks of baseline visit
• PRP in the study eye within 4 month of baseline visit
• Active iris neovascularization in study eye
• Uncontrolled systemic disease
• Known history of IOP elevation in response to corticosteroid treatment that is not controlled on 2 glaucoma medications

Where it is running

• Raj K. Maturi, MD — Indianapolis, Indiana, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.